ANGIODYNAMICS INC — Form 8-K
Filed November 18, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
AngioDynamics filed an 8-K on November 18, 2026, disclosing Item 5.02 (officer/director departure and compensatory arrangements) and Item 5.07 (shareholder vote). No specific names, amounts, or vote details are provided in the filing header—only that matters were submitted to shareholder vote and certain officers departed. The actual text of the 8-K is not included in this extract.
Why this rating
Officer departures and shareholder votes are routine governance events. Without disclosed compensation amounts, severance terms, or strategic context, impact is indeterminate but typical.
Extracted items
- 5.02 exec change
- 5.07 shareholder vote
- 9.01 exhibits
See more from November 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.